Centinel Spine™ Implants Its First STALIF® MIDLINE II-Ti™ Device

NEW YORK, July 28, 2015 /PRNewswire/ -- Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile^®, Integrated Interbody™ fusion devices implants its first two STALIF^® MIDLINE II-Ti devices at Texas Health Plano, Plano, TX and Florida Hospital Carrollwood, Tampa, FL.  The MIDLINE II-Ti devices were implanted by Jessica Shellock, M.D., Texas Back Institute^®, Plano. TX, and James Billys, MD, Florida Orthopaedic Institute^®, North Tampa, FL.

"As a surgeon, MIDLINE II-Ti is the kind of technology I want to provide my patients," said Dr. Shellock.  "I am impressed and pleased with the simplicity of implantation, the immediate stability of the device and the visibility of the titanium coating on the postoperative imaging," she continued.

The MIDLINE II-Ti device is designed with Ti-ACTIVE™, a multidimensional, texturized titanium coating engineered with over 15 years of science and experience to provide primary stability with an optimized topography enabling cellular attachment and proliferation as observed in a preclinical analysis.  MIDLINE II-Ti is a no-profile anterior lumbar Integrated Interbody system used to treat degenerative pathologies in the lumbar spine.

Dr. Billys explained, "I have used STALIF ALIF implants for many years with excellent clinical outcomes as well as high fusion rates.  I recently had the opportunity to place the new MIDLINE II-Ti, which has the same easy placement as the PEEK cage with the added advantages of the titanium coating."

In addition to our Ti-ACTIVE coated MIDLINE II product family, Centinel Spine also offers Ti-ACTIVE in its STALIF C^®, No Profile, Integrated Interbody system for anterior cervical spinal fusion procedures.  Both STALIF C-Ti and MIDLINE II-Ti are available for use in spinal fusion procedures by contacting Centinel Spine.

"We are excited to provide this unique technology to patients around the world and to have the first few MIDLINE II-Ti devices implanted by Dr. Shellock and Dr. Billys," explained John J. Viscogliosi, Chairman & CEO, Centinel Spine.  "MIDLINE II-Ti continues our commitment to being the market leader by advancing the standard of care in spinal fusion procedures with our clinical proven STALIF technology," John concluded.

About Centinel Spine, Inc.

Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies.  For more information on Centinel Spine products and technologies, please visit the Company's web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD.   Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generating superior clinical outcomes.

Centinel Spine derived its name from the "Sentinel Sign" – the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380                                             
Phone: 484-887-8810
Email: cs@centinelspine.com

SOURCE Centinel Spine, Inc.